Beyfortus 유럽 연합 - 리투아니아어 - EMA (European Medicines Agency)

beyfortus

astrazeneca ab - nirsevimab - imuninės serumai ir imunoglobulinai, - beyfortus is indicated for the prevention of respiratory syncytial virus (rsv) lower respiratory tract disease in neonates and infants during their first rsv season. beyfortus should be used in accordance with official recommendations.